Vaccinex, Inc.

EDGAR

Annual consolidated revenue for 2024: about USD 601K, using the latest filing vintage with reviewed corrections applied. Corrected values apply reviewed corrections and remain separate from issuer reports. The previous period, 2023, was about USD 570K.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

This issuer has insider filings in the store, but no transaction in this window or code group.

See all insider transactions

Latest quarter

Revenue

213 thousand USD

2024 Q4 · USD

Exact inputs and evidence

Operating margin

-1,590.14%

2024 Q4 · %

Exact inputs and evidence
  • Operating Income: -18735000 USD Source
  • Operating Income: -15348000 USD Source
  • Revenue: 601000 USD Source
  • Revenue: 388000 USD Source

Operating cash flow

-3.9 million USD

2024 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -16200000 USD Source
  • Operating Cash Flow: -12300000 USD Source

Free cash flow

-3.9 million USD

2024 Q4 · USD

Exact inputs and evidence
  • Operating Cash Flow: -16200000 USD Source
  • Operating Cash Flow: -12300000 USD Source
  • Capital Expenditure: 22000 USD Source
  • Capital Expenditure: 22000 USD Source
Cash and cash equivalents
1.11 million USD Source
Exact value

1107000 USD

Long-term debt including current maturities
25 thousand USD Derived
Exact inputs and evidence

25000 USD

Calculated as noncurrent long-term debt plus its current portion.

  • Current portion of long-term debt: 25000 USD Source
  • Long-term debt: 0 USD Source
Shares outstanding
2.68 million shares Source
Exact value

2676637 shares

Reported share-count change

199.86% · 1.78 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 892617 shares · 2023-12-31· Source
  • 2676637 shares · 2024-12-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

601 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Revenue: 104000 USD · 2024-01-01 – 2024-03-31 Source
  • Revenue: 232000 USD · 2024-04-01 – 2024-06-30 Source
  • Revenue: 52000 USD · 2024-07-01 – 2024-09-30 Source
  • Revenue: 601000 USD · 2024-01-01 – 2024-12-31 Source
  • Revenue: 388000 USD · 2024-01-01 – 2024-09-30 Source

Net income

-18.6 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Net income: -3897000 USD · 2024-01-01 – 2024-03-31 Source
  • Net income: -5631000 USD · 2024-04-01 – 2024-06-30 Source
  • Net income: -5732000 USD · 2024-07-01 – 2024-09-30 Source
  • Net income: -18634000 USD · 2024-01-01 – 2024-12-31 Source
  • Net income: -15260000 USD · 2024-01-01 – 2024-09-30 Source

Operating cash flow

-16.2 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Operating cash flow: -4600000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -9000000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -4600000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -12300000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -9000000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -16200000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -12300000 USD · 2024-01-01 – 2024-09-30 Source

Capital expenditure

22 thousand USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 14000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 14000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-09-30 Source

Free cash flow

-16.2 million USD

2024-01-01 – 2024-12-31

Exact inputs and evidence
  • Operating cash flow: -4600000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -9000000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -4600000 USD · 2024-01-01 – 2024-03-31 Source
  • Operating cash flow: -12300000 USD · 2024-01-01 – 2024-09-30 Source
  • Operating cash flow: -9000000 USD · 2024-01-01 – 2024-06-30 Source
  • Operating cash flow: -16200000 USD · 2024-01-01 – 2024-12-31 Source
  • Operating cash flow: -12300000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 14000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 0 USD · 2024-01-01 – 2024-03-31 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-09-30 Source
  • Capital expenditure: 14000 USD · 2024-01-01 – 2024-06-30 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-12-31 Source
  • Capital expenditure: 22000 USD · 2024-01-01 – 2024-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2025-04-15.

Financial data available through: 2024-12-31.

Coverage by financial measure
  • Revenue: 8 of 11 periods available· newest 2024-12-31
  • Operating income: 8 of 11 periods available· newest 2024-12-31
  • Net income: 8 of 11 periods available· newest 2024-12-31
  • Operating cash flow: 8 of 11 periods available· newest 2024-12-31
  • Capital expenditure: 8 of 11 periods available· newest 2024-12-31
  • Total assets: 8 of 11 periods available· newest 2024-12-31
  • Total liabilities: 8 of 11 periods available· newest 2024-12-31
  • Current assets: 8 of 11 periods available· newest 2024-12-31
  • Current liabilities: 8 of 11 periods available· newest 2024-12-31
  • Cash and cash equivalents: 8 of 11 periods available· newest 2024-12-31
  • long term debt: No compatible figures in this window
  • Shares outstanding: 8 of 11 periods available· newest 2024-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +5.4%

    Prior period

    USD 570,000

    –

    Current period

    USD 601,000

    –

    Exact inputs and evidence

    601000 − 570000 = 31000 USD

    570000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    601000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +USD 1.62 million

    Prior period

    −USD 20.25 million

    –

    Current period

    −USD 18.63 million

    –

    Exact inputs and evidence

    -18634000 − -20251000 = 1617000 USD

    -20251000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -18634000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +USD 5.18 million

    Prior period

    −USD 21.38 million

    –

    Current period

    −USD 16.2 million

    –

    Exact inputs and evidence

    -16200000 − -21379000 = 5179000 USD

    -21379000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    -16200000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    -67.2%

    Prior period

    USD 67,000

    –

    Current period

    USD 22,000

    –

    Exact inputs and evidence

    22000 − 67000 = -45000 USD

    67000 USD · 2023-01-01 – 2023-12-31

    Inspect prior input Prior source

    22000 USD · 2024-01-01 – 2024-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2024 2024-01-01 – 2024-12-31

  • Revenue USD 601,000 100% of revenue
  • Operating costs Derived USD 19.34 million 3,217% of revenue
  • Operating income −USD 18.74 million −3,117% of revenue
  • Tax, interest and other Derived −USD 101,000 −17% of revenue
  • Net income −USD 18.63 million −3,100% of revenue

Cash

  • Operating cash flow −USD 16.2 million −2,696% of revenue
  • Capital expenditure USD 22,000 3.7% of revenue
  • Free cash flow Derived −USD 16.22 million −2,699% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2017 Operating loss: operating costs were 23,549% of revenue.
  • 2018 Operating loss: operating costs were 3,868% of revenue.
  • 2019 Operating loss: operating costs were 6,221% of revenue.
  • 2020 Operating loss: operating costs were 4,633% of revenue.
  • 2021 Operating loss: operating costs were 2,599% of revenue.
  • 2022 Operating loss: operating costs were 7,339% of revenue.
  • 2023 Operating loss: operating costs were 4,115% of revenue.
  • 2024 Operating loss: operating costs were 3,217% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2017 2017-01-01 – 2017-12-3190000 21194000 Derived -21104000 -2382000 Derived -18722000 -21455000 Derived
Source
2018 2018-01-01 – 2018-12-31724000 28005000 Derived -27281000 2237000 Derived -29518000 -25511000 Derived
Source
2019 2019-01-01 – 2019-12-31523000 32538000 Derived -32015000 -152000 Derived -31863000 -30793000 Derived
Source
2020 2020-01-01 – 2020-12-31625000 28956000 Derived -28331000 520000 Derived -28851000 -28890000 Derived
Source
2021 2021-01-01 – 2021-12-31900000 23390000 Derived -22490000 -110000 Derived -22380000 -25332000 Derived
Source
2022 2022-01-01 – 2022-12-31275000 20181000 Derived -19906000 -91000 Derived -19815000 -19199000 Derived
Source
2023 2023-01-01 – 2023-12-31570000 23455000 Derived -22885000 -2634000 Derived -20251000 -21446000 Derived
Source
2024 2024-01-01 – 2024-12-31601000 19336000 Derived -18735000 -101000 Derived -18634000 -16222000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 601K 2024
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.972.0K729.0K486.0K243.0K0.0201720212024
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Revenue90000
2018Revenue724000
2019Revenue523000
2020Revenue625000
2021Revenue900000
2022Revenue275000
2023Revenue570000
2024Revenue601000

Revenue growth

Change in revenue from the same financial period one year earlier.

5.4% 2024
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.766%542%318%93%-131%201720212024
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2017Year over yearNo prior comparable period
2018Year over year704.4%
2019Year over year-27.8%
2020Year over year19.5%
2021Year over year44%
2022Year over year-69.4%
2023Year over year107.3%
2024Year over year5.4%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -3,117.3% 2024
Net margin -3,100.5% 2024
Free cash flow margin -2,699.2% 2024
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1,907%-5,006%-11,919%-18,833%-25,746%201720212024
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2017Operating margin-23,448.9%
2018Operating margin-3,768.1%
2019Operating margin-6,121.4%
2020Operating margin-4,533%
2021Operating margin-2,498.9%
2022Operating margin-7,238.5%
2023Operating margin-4,014.9%
2024Operating margin-3,117.3%
2017Net margin-20,802.2%
2018Net margin-4,077.1%
2019Net margin-6,092.4%
2020Net margin-4,616.2%
2021Net margin-2,486.7%
2022Net margin-7,205.5%
2023Net margin-3,552.8%
2024Net margin-3,100.5%
2017Free cash flow margin-23,838.9%
2018Free cash flow margin-3,523.6%
2019Free cash flow margin-5,887.8%
2020Free cash flow margin-4,622.4%
2021Free cash flow margin-2,814.7%
2022Free cash flow margin-6,981.5%
2023Free cash flow margin-3,762.5%
2024Free cash flow margin-2,699.2%

Operating cash flow

Cash generated by the company’s normal business operations.

USD -16.2M 2024
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.5M-6.5M-15.4M-24.3M-33.2M201720212024
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Operating cash flow-21387000
2018Operating cash flow-25276000
2019Operating cash flow-30715000
2020Operating cash flow-28600000
2021Operating cash flow-25300000
2022Operating cash flow-19100000
2023Operating cash flow-21379000
2024Operating cash flow-16200000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -16.2M 2024
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.2.5M-6.5M-15.4M-24.3M-33.3M201720212024
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2017Free cash flow-21455000
2018Free cash flow-25511000
2019Free cash flow-30793000
2020Free cash flow-28890000
2021Free cash flow-25332000
2022Free cash flow-19199000
2023Free cash flow-21446000
2024Free cash flow-16222000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

195.8% 2024
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.212%159%106%53%0%201720212024
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2017Liabilities / assets131.8%
2018Liabilities / assets30.4%
2019Liabilities / assets149.4%
2020Liabilities / assets122.3%
2021Liabilities / assets24.7%
2022Liabilities / assets34.9%
2023Liabilities / assets163.6%
2024Liabilities / assets195.8%

Current assets to current liabilities

Current assets divided by current liabilities.

0.5× 2024
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.50×3.38×2.25×1.13×0.00×201720212024
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2017Current assets / current liabilities1.19×
2018Current assets / current liabilities3.2×
2019Current assets / current liabilities0.58×
2020Current assets / current liabilities0.86×
2021Current assets / current liabilities4.17×
2022Current assets / current liabilities2.95×
2023Current assets / current liabilities0.57×
2024Current assets / current liabilities0.5×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2017 2017-01-01 – 2017-12-31
−USD 18.72 million
Exact value

Exact value: -18722000 USD

2017-01-01 – 2017-12-31: -18722000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.39 million
Exact value

Exact value: -21387000 USD

2017-01-01 – 2017-12-31: -21387000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 68,000
Exact value

Exact value: 68000 USD

2017-01-01 – 2017-12-31: 68000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.46 million
Calculation and evidence

-21387000 − 68000 USD

Exact free cash flow: -21455000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 29.52 million
Exact value

Exact value: -29518000 USD

2018-01-01 – 2018-12-31: -29518000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.28 million
Exact value

Exact value: -25276000 USD

2018-01-01 – 2018-12-31: -25276000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 235,000
Exact value

Exact value: 235000 USD

2018-01-01 – 2018-12-31: 235000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.51 million
Calculation and evidence

-25276000 − 235000 USD

Exact free cash flow: -25511000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 31.86 million
Exact value

Exact value: -31863000 USD

2019-01-01 – 2019-12-31: -31863000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.72 million
Exact value

Exact value: -30715000 USD

2019-01-01 – 2019-12-31: -30715000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 78,000
Exact value

Exact value: 78000 USD

2019-01-01 – 2019-12-31: 78000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 30.79 million
Calculation and evidence

-30715000 − 78000 USD

Exact free cash flow: -30793000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
−USD 28.85 million
Exact value

Exact value: -28851000 USD

2020-01-01 – 2020-12-31: -28851000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.6 million
Exact value

Exact value: -28600000 USD

2020-01-01 – 2020-12-31: -28600000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 290,000
Exact value

Exact value: 290000 USD

2020-01-01 – 2020-12-31: 290000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.89 million
Calculation and evidence

-28600000 − 290000 USD

Exact free cash flow: -28890000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 22.38 million
Exact value

Exact value: -22380000 USD

2021-01-01 – 2021-12-31: -22380000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.3 million
Exact value

Exact value: -25300000 USD

2021-01-01 – 2021-12-31: -25300000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 32,000
Exact value

Exact value: 32000 USD

2021-01-01 – 2021-12-31: 32000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 25.33 million
Calculation and evidence

-25300000 − 32000 USD

Exact free cash flow: -25332000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
−USD 19.82 million
Exact value

Exact value: -19815000 USD

2022-01-01 – 2022-12-31: -19815000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.1 million
Exact value

Exact value: -19100000 USD

2022-01-01 – 2022-12-31: -19100000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 99,000
Exact value

Exact value: 99000 USD

2022-01-01 – 2022-12-31: 99000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.2 million
Calculation and evidence

-19100000 − 99000 USD

Exact free cash flow: -19199000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
−USD 20.25 million
Exact value

Exact value: -20251000 USD

2023-01-01 – 2023-12-31: -20251000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.38 million
Exact value

Exact value: -21379000 USD

2023-01-01 – 2023-12-31: -21379000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 67,000
Exact value

Exact value: 67000 USD

2023-01-01 – 2023-12-31: 67000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 21.45 million
Calculation and evidence

-21379000 − 67000 USD

Exact free cash flow: -21446000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
−USD 18.63 million
Exact value

Exact value: -18634000 USD

2024-01-01 – 2024-12-31: -18634000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 16.2 million
Exact value

Exact value: -16200000 USD

2024-01-01 – 2024-12-31: -16200000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 22,000
Exact value

Exact value: 22000 USD

2024-01-01 – 2024-12-31: 22000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 16.22 million
Calculation and evidence

-16200000 − 22000 USD

Exact free cash flow: -16222000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

62 filings · 1,943 latest values · 1,943 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001205922, 1205922, VCNX, edgar:1205922

Also known as VACCINEX INC, VACCINEX, INC., Vaccinex, Inc.